Counterfeit Semaglutide: What the Fake Pen Trade Looks Like and How to Avoid It

You've found a listing that looks almost right, here's what's actually being sold

Picture the scenario a lot of buyers describe: a social media account, often with a blue tick or a convincing follower count, posts about weight-loss pens at prices well below anything a registered pharmacy charges. The packaging in the photos looks close to the real thing. There's no waiting, no consultation, and payment goes through a direct bank transfer or a cryptocurrency wallet.

What arrives (if anything does) is unlikely to be genuine semaglutide. The MHRA's analysis of seized fake pens has found insulin, plain water and unidentified compounds where the active ingredient should be. Insulin injected by someone without diabetes can cause blood glucose to drop to a level that causes seizures or loss of consciousness. The first major public warning came in October 2023, when hundreds of counterfeit pens were seized and a pattern of hospitalisations linked to fake products was documented. Enforcement has continued at scale: by 2025, approximately 20 million doses of illegally traded weight-loss medicines worth around £45 million had been seized across UK operations, and a facility in Northampton was found to be manufacturing fake tirzepatide pens domestically.

The fakes travel through the same visual channels that legitimate health content does. That's the point. Anyone wondering whether Wegovy can be bought over the counter is a target. Understanding that the answer is no (and why) is the first protective layer.

The red flags: what a counterfeit seller looks like in practice

A question our prescribers hear most weeks is some version of: "I saw it for £60 a pen online, is that the same thing?" It is not. Legitimate private supply costs substantially more because it includes a prescriber's clinical assessment, a pharmacy's dispensing check, cold-chain logistics and genuine regulatory oversight. Current market rates for semaglutide from registered UK pharmacies run considerably higher than that; the short version is that a price dramatically below the market is a signal, not a saving.

Specific red flags the MHRA has highlighted include: offers made without any requirement for a prescription or medical history; payment via bank transfer, cryptocurrency or gift cards; sellers operating purely through social media direct messages or messaging apps; pens arriving without a UK patient information leaflet, a pharmacy dispensing label, or a GPhC registration number; and packaging that is slightly different in font, colour or texture from the genuine article. You can check the legal status of semaglutide in the UK, it is a prescription-only medicine, full stop.

If you have received or suspect a product, the MHRA's Yellow Card scheme lets you report both suspected adverse reactions and suspect sellers. That reporting is genuinely useful: it feeds into enforcement and, in some cases, triggers product recalls.

What legitimate semaglutide supply actually involves

Genuine Wegovy travels from Novo Nordisk through an authorised UK distribution chain to a GPhC-registered pharmacy, dispensed against a prescription written by a registered prescriber who has assessed you. That chain has audit points at every stage. The pen you receive will carry a pharmacy label with your name, the prescriber's name and the GPhC registration of the dispensing pharmacy. Cold-chain integrity is maintained throughout, because semaglutide degrades if it leaves the correct temperature range, something unregulated sellers have no infrastructure to manage.

Verifying an online pharmacy takes less than a minute. The GPhC register lists every legally operating pharmacy in Great Britain by name and registration number. If a seller is not on it, they cannot lawfully dispense prescription medicines to UK patients. Full stop.

The cost context is worth stating plainly: the price of semaglutide from registered UK pharmacies reflects genuine cold-chain supply, a prescriber's time, dispensing, and tracked delivery. It will never match a social-media listing. That gap is not a failure of the regulated market; it's what safety costs. If you want to understand what a compliant private weight-loss pathway looks like end to end, the semaglutide overview on this site lays it out, and the about us page details how our pharmacy and prescribers are regulated.

If you've already used a product you're now unsure about

Stop using it and contact a healthcare professional today. A GP, pharmacist or 111 can assess whether you need any immediate checks. The priority symptoms to flag are unexpected hypoglycaemia (shakiness, sweating, confusion, rapid heartbeat), any signs of an allergic reaction, or severe gastrointestinal symptoms beyond what legitimate GLP-1 treatment typically causes. Bring whatever packaging you have, the prescriber or pharmacist will want to see it, and if you are concerned about effects you have already experienced, our guidance on how to counteract semaglutide explains what steps can help.

The NHS guidance on weight-management medicines notes clearly that patients should only use GLP-1 medicines under clinical supervision, a point that applies to the question of what to do if something has gone wrong as much as to starting treatment safely. NHS England's guidance on weight-management injections outlines the safeguards that genuine supply involves.

If you're considering a legal, clinically supervised route to semaglutide, our free consultation is the starting point. A real prescriber reviews every application; no algorithm makes the call.